Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AMI Organics has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 10, 2024 at the Registered Office of the Company, to transact the following matters: 1. To consider and approve the Audited Standalone & Consolidated Financial Statements and Results of the Company for the quarter and year ended March 31, 2024. 2. To consider the recommendation of Final Dividend for the F.Y. 2023-24 to equity shareholders of Company, subject to the approval by members in the ensuing Annual General Meeting. 3. Other business matters. The Board Meeting shall be preceded by Audit Committee Meeting on the same day. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with our intimation letter dated March 28, 2024 it was informed that the Trading Window for dealing in shares of the Company by designated persons, shall remain closed from April 1, 2024 until 48 hours after the declaration of financial results by the Company for the fourth quarter and year ended March 31, 2024. Accordingly, the trading window shall remain closed until Sunday, May 12, 2024 and shall reopen on the next day.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |